Hospitalization-related costs among patients with atrial fibrillation treated with the factor Xa inhibitor edoxaban vs warfarin: results from the ENGAGE AF-TIMI 48 trial
Event:
ESC Congress 2016
Topic:
Atrial fibrillation (AF)
Session:
Antithrombotic therapy in atrial fibrillation 2
